NEPH — NEPHROS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1196298 ·
Last close
$3.58
Market Cap
$38.87M
52W High
$4.24
52W Low
$2.66
ADV30
32,121
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,212,000 | 2,993,000 | 97,000 | 140,000 | 13,794,000 | 4,018,000 | 3,093,000 |
| Dec 2025 | 4,729,000 | 2,761,000 | 18,000 | 62,000 | 13,641,000 | 5,400,000 | 3,439,000 |
| Sep 2025 | 4,764,000 | 2,915,000 | 314,000 | 337,000 | 13,247,000 | 5,171,000 | 3,241,000 |
| Jun 2025 | 4,419,000 | 2,795,000 | 248,000 | 237,000 | 12,243,000 | 5,074,000 | 2,644,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,645,000
Investing CF
$0
Financing CF
$-5,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.13
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-143,138,000
Inventory
$3,232,000
Receivables
$2,414,000
ST Investments
—
EBIT TTM
$1,207,000
Pretax Income TTM
$1,206,000
Interest Exp TTM
$1,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,124,000
EBITDA
$803,000
Free Cash Flow
$-773,500
Enterprise Value
$34,622,216
Total Cash
$4,018,000
Total Debt
$968,000
Shares Out
10,856,546
Trailing EPS
$0.07
Book Value
$0.99
ROE
7.8%
ROA
3.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,789,000 | 1,146,000 | 1,194,000 | 13,641,000 | 3,439,000 | — | 1,645,000 |
| Dec 2024 | 14,162,000 | 6,000 | 74,000 | 11,210,000 | 2,625,000 | — | -492,000 |
| Dec 2023 | 14,238,000 | -1,593,000 | -1,575,000 | 11,861,000 | 3,503,000 | — | 827,000 |
| Dec 2022 | 9,975,000 | -4,335,000 | -7,382,000 | 10,999,000 | 2,118,000 | — | -3,234,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.10
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MCAG | Mountain Crest Acquisition Corp. V | $38.13M | $13.27 | — |
| MYO | MYOMO, INC. | $39.80M | $1.03 | — |
| VASO | VASO Corp | $40.30M | $0.23 | — |
| TELA | TELA Bio, Inc. | $36.44M | $0.81 | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $36.42M | $1.20 | — |
News headlines (Yahoo Finance, 1h cache)
US$7.00 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results
2026-05-11 11:50 · Yahoo
Nephros, Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Nephros Announces Financial Results for Quarter Ended March 31, 2026
2026-05-07 20:05 · Yahoo
Nephros Schedules First Quarter 2026 Financial Results Conference Call
2026-04-30 20:00 · Yahoo
3 Promising Penny Stocks With Market Caps Under $200M
2026-04-30 18:05 · Yahoo
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
2026-04-16 13:57 · Yahoo
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
2026-04-01 13:00 · Yahoo
Nephros Inc (NEPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures
2026-03-14 01:02 · Yahoo
Nephros (NEPH) Q4 2025 Earnings Call Transcript
2026-03-13 13:25 · Yahoo
Nephros, Inc. Q4 2025 Earnings Call Summary
2026-03-13 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.